Hepatic hemodynamics in 24 patients with nodular regenerative hyperplasia and symptomatic portal hypertension

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 8, 2012, Pages 1336-1340

  Bissonnette, Julien ^a   Généreux, Alexandre ^c   Côté, Jean ^b   Nguyen, Bich ^b   Perreault, Pierre ^b   Bouchard, Louis ^b   Pomier Layrargues, Gilles ^a  

^a Liver Unit   (Canada)

^b Department of Pathology CHUM St Luc ^*  (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Ascites; Esophageal varices; Nodular regenerative hyperplasia; Portal hypertension; Portohepatic gradient; Splenomegaly

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; SERUM ALBUMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASCITES; CHOLESTASIS; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GRAFT FAILURE; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HEPATIC HEMODYNAMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFERIOR CAVA VEIN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MALE; NODULAR HYPERPLASIA; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLENOMEGALY; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT REFUSAL;

EID: 84864316842     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07168.x     Document Type: Article

References (44)

1. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-97.
2. Nakanuma Y, Hoso M, Sasaki M etal. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996; 28: 195-204.
3. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44: 7-13.
4. Morris JM, Oien KA, McMahon M etal. Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series. Eur. J. Gastroenterol. Hepatol. 2010; 22: 1001-5.
5. Hartleb M, Gutkowski K, Milkiewicz P. Nodular regenerative hyperplasia of the liver: evolving concepts on underdiagnosed cause of portal hypertension. World J. Gastroenterol. 2011; 17: 1400-9.
6. Ueno S, Tanabe G, Sueyoshi K. Hepatic hemodynamics in a patient with nodular regenerative hyperplasia. Am. J. Gastroenterol. 1996; 91: 1012-15.
7. Gento-Pena E, Martín-Lorente JL, Echevarría-Iturbe C etal. Sinusoidal portal hypertension secondary to nodular regenerative hyperplasia of the liver. Gastroenterol. Hepatol. 1999; 22: 183-5.
8. Arvanitaki M, Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001; 48: 1425-9.
9. Viallet A, Joly JG, Marleau D, Lavoie P. Comparison of the free portal venous pressure and wedged hepatic venous pressure in patients with cirrhosis of the liver. Gastroenterology 1970; 59: 372-5.
10. Garcia-Tsao G, Groszman RJ, Fisher RC etal. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985; 5: 419-24.
11. Wadhawan M, Dubey S, Sharma BC etal. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites and Child's status. Dig. Dis. Sci. 2006; 51: 2264-9.
12. Kaburaki J, Kuramochi S, Fujii T etal. Nodular regenerative hyperplasia of the liver in a patient with systemic sclerosis. Clin. Rheumatol. 1996; 15: 613-16.
13. Gonzalez-Alvaro I, Carmona-Ortell L, Amigo-Etxenagusia A etal. Nodular regenerative hyperplasia of the liver and primary Sjogren's syndrome. J. Rheumatol. 1994; 21: 168-9.
14. Bloxham CA, Henderson DC, Hampson J etal. Nodular regenerative hyperplasia of the liver in Behçet's disease. Histopathology 1992; 20: 452-4.
15. Perez Ruiz F, Orte Martinez FJ, Zea Mendora AC etal. Nodular regenerative hyperplasia of the liver in rheumatic diseases: report of seven cases and review of the literature. Semin. Arthritis Rheum. 1991; 21: 47-54.
16. Nakanuma Y, Ohta G, Sasaki K. Nodular regenerative hyperplasia of the liver associated with polyarteritis nodosa. Arch. Pathol. Lab. Med. 1984; 108: 133-5.
17. Walker NJ, Zurier RB. Liver abnormalities in rheumatic diseases. Clin. Liver Dis. 2002; 6: 933-46.
18. Chanet V, Dubost JJ, Abergel A etal. Nodular regenerative hyperplasia of the liver and polymyositis. Gastroenterol. Clin. Biol. 2001; 25: 713-14.
19. Snover DC, Weisdorf S, Bloomer J etal. Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989; 9: 443-8.
20. Pezzullo L, Muretto P, De Rosa G etal. Liver nodular regenerative hyperplasia after bone marrow transplant. Haematologica 2000; 85: 669-70.
21. Wanless IR, Solt LC, Kortan P etal. Nodular regenerative hyperplasia of the liver associated with macroglobulinemia. A clue to the pathogenesis. Am. J. Med. 1981; 70: 1203-9.
22. Uthman I, Khamashta M. The abdominal manifestations of the antiphospholipid syndrome. Rheumatology (Oxford) 2007; 46: 1641-7.
23. Malamut G, Ziol M, Suarez F etal. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J. Hepatol. 2008; 48: 74-82.
24. Ward C, Lucas M, Piris J etal. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin. Exp. Immunol. 2008; 153: 331-7.
25. Bryant DL, Miles CJ, Gearry RB. Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease. N. Z. Med. J. 2010; 123: 74-6.
26. Nahon S, Cardanel JF, Chazouilleres O etal. Liver and inflammatory bowel disease. Gastroenterol. Clin. Biol. 2009; 33: 370-81.
27. Dubinsky MC, Vasiliauskas EA, Singh H etal. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003; 125: 298-303.
28. Ferlitsch A, Teml A, Reinisch W etal. 6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension. Am. J. Gastroenterol. 2007; 102: 2495-503.
29. Vernier-Massouille G, Cosnes J, Lemann M etal. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007; 56: 1404-9.
30. Daniel F, Cadranel JF, Seksik P. Azathioprine induced nodular regenerative hyperplasia in IBD patients. Gastroenterol. Clin. Biol. 2005; 29: 600-3.
31. Mendizabal M, Craviotto S, Silva MO etal. Noncirrhotic portal hypertension: another cause of liver disease in HIV patients. Ann. Hepatol. 2009; 8: 390-5.
32. Mallet VO, Varthaman A, Lasne D etal. Acquired protein S deficiency leads to portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS 2009; 23: 1511-18.
33. Dinh MH, Stosor V, Rao SM etal. Cryptogenic liver disease in HIV-seropositive men. HIV Med. 2009; 10: 447-53.
34. Arey B, Markov M, Ravi J. Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS 2007; 21: 1066-8.
35. Podevin P, Spiridon G, Terris B etal. Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient. AIDS 2006; 20: 313-15.
36. Maida I, Nunez M, Rios MJ etal. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J. Acquir. Immune Defic. Syndr. 2006; 42: 177-82.
37. Saifee S, Joelson J, Braude J etal. Noncirrhotic portal hypertension in patients with Human Immunodeficiency Virus-1 Infection. Clin. Gastroenterol. Hepatol. 2008; 6: 1167-9.
38. Van den Broek MA, Olde Damink SW, Driessen A etal. Nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastases. Case Report. Med. 2009; 457975 Nov 22 (Epub ahead of print).
39. Hubert C, Sampoux C, Horsmans Y etal. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? Liver Int. 2007; 27: 938-43.
40. Gane E, Portmann B, Saxena R etal. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994; 20: 88-94.
41. Dumortier J, Boillot O, Chevalier M etal. Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families. Gut 1999; 45: 289-94.
42. Grazioli L, Alberti D, Olivetti L etal. Congenital absence of portal vein with nodular regenerative hyperplasia of the liver. Eur. Radiol. 2000; 10: 820-5.
43. Naber AHJ, Van Haelst U, Yap SH. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J. Hepatol. 1991; 12: 94-9.
44. D'Amico G, Garcia-Pagan JC, Luca A etal. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 2006; 131: 1611-24.